Dystonia-Ataxia with early handwriting deterioration in COQ8A mutation carriers: A case series and literature review.

Serena Galosi, Emanuele Barca, Rosalba Carrozzo, Tommaso Schirinzi, Catarina Maria Quinzii, Maria Lieto, Gessica Vasco, Ginevra Zanni, Michela Di Nottia, Daniele Galatolo, Alessandro Filla, Enrico Bertini, Filippo Maria Santorelli, Vincenzo Leuzzi, Richard Haas, Michio Hirano, Jennifer Friedman

Journal: Parkinsonism & related disorders 2020;68():8-16

PMID: 31621627

Abstract

Cerebellar ataxia is a hallmark of coenzyme Q (CoQ) deficiency associated with COQ8A mutations. We present four patients, one with novel COQ8A pathogenic variants all with early, prominent handwriting impairment, dystonia and only mild ataxia. To better define the phenotypic spectrum and course of COQ8A disease, we review the clinical presentation and evolution in 47 reported cases. Individuals with COQ8A mutation display great clinical variability and unpredictable responses to CoQ supplementation. Onset is typically during infancy or childhood with ataxic features associated with developmental delay or regression. When disease onset is later in life, first symptoms can include: incoordination, epilepsy, tremor, and deterioration of writing. The natural history is characterized by a progression to a multisystem brain disease dominated by ataxia, with disease severity inversely correlated with age at onset. Six previously reported cases share with ours, a clinical phenotype characterized by slowly progressive or static writing difficulties, focal dystonia, and speech disorder, with only minimal ataxia. The combination of writing difficulty, dystonia and ataxia is a distinctive constellation that is reminiscent of a previously described clinical entity called Dystonia Ataxia Syndrome (DYTCA) and is an important clinical indicator of COQ8A mutations, even when ataxia is mild or absent.

Copyright © 2019. Published by Elsevier Ltd.

Address: Department of Human Neuroscience, Sapienza University, Rome, Italy.; Department of Neurology and H. Houston Merritt Neuromuscular Clinical Research Center, Columbia University Irving Medical Center, New York, NY, USA.; Unit of Muscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children Hospital, Rome, Italy.; Unit of Muscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children Hospital, Rome, Italy; Department of Systems Medicine, University of Roma Tor Vergata, Rome, Italy.; Department of Neurosciences, Reproductive and Odontostomatologic Sciences, Federico II University, Naples, Italy.; Unit of Neurorehabilitation, Department of Neurosciences, IRCCS Bambino Gesù Children Hospital, Rome, Italy.; Molecular Medicine IRCCS Fondazione Stella Maris, Pisa, Italy.; Departments of Neurosciences and Pediatrics, University of California San Diego, San Diego, CA, USA; Division of Neurology Rady Children's Hospital, San Diego, CA, USA.; Departments of Neurosciences and Pediatrics, University of California San Diego, San Diego, CA, USA; Division of Neurology Rady Children's Hospital, San Diego, CA, USA; Rady Children's Institute for Genomic Medicine, San Diego, CA, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.